Back to back announcements of good news.
This is a relatively new one for me in this space, but the news (in links below) of the NIH grant followed by the FDA approval of an additional indication will make following today's stock-price-action of interest!
scynexis.com/news-media/press-releases/detail/313/scynexis-announces-3-million-national-institutes-of-health
scynexis.com/news-media/press-releases/detail/314/scynexis-announces-fda-approval-of-second-indication-for
(NOTE: NOT ADVICE IN ANYWAY!! JUST FOOD FOR THOUGHT AND DISCUSSION!!)
This is a relatively new one for me in this space, but the news (in links below) of the NIH grant followed by the FDA approval of an additional indication will make following today's stock-price-action of interest!
scynexis.com/news-media/press-releases/detail/313/scynexis-announces-3-million-national-institutes-of-health
scynexis.com/news-media/press-releases/detail/314/scynexis-announces-fda-approval-of-second-indication-for
(NOTE: NOT ADVICE IN ANYWAY!! JUST FOOD FOR THOUGHT AND DISCUSSION!!)
Feragatname
Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, alım satım veya diğer türden tavsiye veya öneriler anlamına gelmez ve teşkil etmez. Kullanım Koşulları bölümünde daha fazlasını okuyun.
Feragatname
Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, alım satım veya diğer türden tavsiye veya öneriler anlamına gelmez ve teşkil etmez. Kullanım Koşulları bölümünde daha fazlasını okuyun.